Conferences
SUO 2017: Validation of The Preoperative Nomogram Predicting 12-Year Probability of Metastatic Renal Cancer
December 5, 2017
SUO 2017: Keynote-564: Phase 3, Double-blind, Placebo-controlled Trial Of Pembrolizumab As Adjuvant Treatment For Renal Cell Carcinoma
December 5, 2017
SUO 2017: Sarcomatoid Differentiation in Renal Cell Carcinoma: Does Stage Make A Meaningful Difference On Survival?
December 5, 2017
SUO 2017: MRI Fusion Biopsy is Associated with a Higher Rate of Pathologic Downgrading at Radical Prostatectomy
December 5, 2017
SUO 2017: Outcomes of Serial MRI/Ultrasound Fusion Targeted Biopsy
December 4, 2017
SUO 2017: The Role of Inguinal Lymph Node Dissection in Men with Urethral Squamous Cell Carcinoma
December 4, 2017
SUO 2017: The REASSURE ME Trial
December 4, 2017
SUO 2017: Oncologic Outcomes Comparing Open and Robot-Assisted Laparoscopic Radical Cystectomy for Bladder Cancer
December 4, 2017
SUO 2017: Primary Focal Cryoablation For Low-, Intermediate- And High-risk Prostate Cancer
December 4, 2017
SUO 2017: Anterior Prostate Lesions and Prostate Cancer Diagnosed in African American Men
December 4, 2017
SUO 2017: The Effect of Agent Orange Exposure on Treatment Choice
December 4, 2017
SUO 2017: Inaccuracy of Clinical Staging After Neoadjuvant Chemotherapy for Muscle Invasive Bladder Cancer
December 4, 2017
SUO 2017: Contemporary Trends in Abiraterone and Enzalutamide Prescription by Provider Specialty
December 4, 2017
SUO 2017: Does Insurance Status Lead to a Delay in Therapy - Patient Presenting with Metastatic Prostate Cancer?
December 4, 2017